[조사 보고서] 세계의 유전성 혈관 부종 (HAE) 치료제 시장 2023-2027

■ 영문 제목 : Global Hereditary Angioedema Therapeutics Market 2023-2027
	■ 상품코드 : IRTNTR75935-23 ■ 조사/발행회사 : Technavio ■ 발행일 : 2023년 7월 ■ 페이지수 : 약120 ■ 작성언어 : 영문 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (주문후 24시간내) ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD2,500 ⇒환산￦3,500,000	견적의뢰/주문/질문
Enterprise License (기업 열람용)	USD4,000 ⇒환산￦5,600,000	견적의뢰/주문/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

글로벌 유전성 혈관 부종 (HAE) 치료제 시장 2023-2027
유전성 혈관 부종 (HAE) 치료제 시장은 2022년부터 2027년까지 1억 6,738만 달러 규모로 성장할 것으로 예상되며, 예측 기간 동안 8.95%의 CAGR을 기록할 것으로 예상됩니다. 이 보고서는 유전성 혈관 부종 (HAE) 치료제 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 담고 있습니다.
이 보고서는 현재 시장 시나리오, 최신 동향 및 촉진 요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 유전성 혈관성 부종(HAE) 유병률 증가, 진단 기술 발전, 의료 인프라 성장 등이 시장을 주도하고 있습니다.

Technavio사의 유전성 혈관 부종 (HAE) 치료제 시장은 다음과 같이 분류하고 있습니다.

최종 용도별
- 병원 약국
- 소매 약국
- 전자 상거래

제품별
- C1-에스테라아제 억제제
- 브라지키닌 B2 수용체 길항제
- 칼리크레인 억제제
- 기타

지역별
- 북미
- 유럽
- 아시아
- 기타 지역(ROW)

이 보고서는 향후 몇 년 동안 유전성 혈관 부종 (HAE) 치료제 시장의 성장을 촉진하는 주요 이유 중 하나로 개인 맞춤형 의료에 대한 수요 증가를 꼽고 있습니다. 또한, 단일 클론 항체 및 유전자 치료와 같은 혁신적이고 효과적인 치료제의 개발, 희귀질환 치료제 개발을 위한 R&D 및 자금 조달의 증가는 시장의 큰 수요로 이어질 것으로 보입니다.

본 보고서는 유전성 혈관 부종 (HAE) 치료제 시장을 조사하고 분석한 결과를 담고 있습니다.
- 유전성 혈관 부종 (HAE) 치료제 시장 규모
- 유전성 혈관 부종 (HAE) 치료제 시장 예측
- 유전성 혈관 부종 (HAE) 치료제 시장 산업 분석

고객이 시장에서의 입지를 강화할 수 있도록 돕는 견고한 벤더 분석은 이 보고서에서 Adverum Biotechnologies Inc., Arrowhead Pharmaceuticals Inc., Attune Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., BioMarin Pharmaceutical Inc., CENTOGENE NV, Cipla Ltd., CSL Ltd., Diapharma Group Inc., Intellia Therapeutics Inc., Ionis Pharmaceuticals Inc., KalVista Pharmaceuticals Inc., Pharming Group NV, Pharvaris NV, Sanofi, 및 Takeda Pharmaceutical Co. Ltd 등을 분석하고 있습니다. 또한, 유전성 혈관 부종 (HAE) 치료제도 개발되고 있습니다. 유전성 혈관 부종 (HAE) 치료제 시장 분석 보고서에는 시장 성장에 영향을 미치는 향후 동향과 과제에 대한 정보도 포함되어 있습니다. 이는 기업이 전략을 수립하고 다가오는 모든 성장 기회를 활용하는 데 도움이 될 것으로 예상되고 있습니다.

이 연구는 업계 주요 참여자들의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 이 보고서는 주요 벤더에 대한 분석과 함께 포괄적인 시장 및 벤더 현황을 제공합니다.

이 보고서는 이익, 가격, 경쟁, 프로모션 등 주요 매개변수를 분석하여 여러 출처의 데이터를 조사, 통합, 요약하는 방식으로 시장의 상세한 모습을 제시합니다. 또한, 주요 산업 영향력자를 식별하여 시장의 다양한 측면을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 시장 조사 보고서는 정확한 시장 성장을 예측하기 위해 완전한 경쟁 환경과 정성적 및 정량적 조사를 통한 면밀한 공급업체 선정 방법 및 분석을 제공합니다.

■ 보고서 개요

1. 개요
2. 세계의 유전성 혈관 부종 (HAE) 치료제 시장 현황
3. 세계의 유전성 혈관 부종 (HAE) 치료제 시장 규모
4. 과거 시장 규모
5. 파이브 포스 분석
6. 최종 용도별 시장 분석
7. 제품별 시장 분석
8. 고객 현황
9. 지역별 분석
10. 추진 요인/과제/동향
11. 기업 현황
12. 기업 분석
13. 부록

■ 보고서 목차

1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
o 4.1 Global hereditary angioedema therapeutics market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global hereditary angioedema therapeutics market 2017 – 2021 ($ million)
o 4.2 End-User Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – End-User Segment 2017 – 2021 ($ million)
o 4.3 Product Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Product Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 31: Data Table on End-user – Market share 2022-2027 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Hospital pharmacies – Market size and forecast 2022-2027
o Exhibit 34: Chart on Hospital pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Hospital pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
o 6.4 Retail pharmacies – Market size and forecast 2022-2027
o Exhibit 38: Chart on Retail pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Retail pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Retail pharmacies – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Retail pharmacies – Year-over-year growth 2022-2027 (%)
o 6.5 E-commerce – Market size and forecast 2022-2027
o Exhibit 42: Chart on E-commerce – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on E-commerce – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on E-commerce – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on E-commerce – Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by End-user
o Exhibit 46: Market opportunity by End-user ($ million)
o Exhibit 47: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 48: Chart on Product – Market share 2022-2027 (%)
o Exhibit 49: Data Table on Product – Market share 2022-2027 (%)
o 7.2 Comparison by Product
o Exhibit 50: Chart on Comparison by Product
o Exhibit 51: Data Table on Comparison by Product
o 7.3 C1-esterase inhibitor – Market size and forecast 2022-2027
o Exhibit 52: Chart on C1-esterase inhibitor – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on C1-esterase inhibitor – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on C1-esterase inhibitor – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on C1-esterase inhibitor – Year-over-year growth 2022-2027 (%)
o 7.4 Bradykinin B2 receptor antagonist – Market size and forecast 2022-2027
o Exhibit 56: Chart on Bradykinin B2 receptor antagonist – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Bradykinin B2 receptor antagonist – Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Bradykinin B2 receptor antagonist – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Bradykinin B2 receptor antagonist – Year-over-year growth 2022-2027 (%)
o 7.5 Kallikrein inhibitor – Market size and forecast 2022-2027
o Exhibit 60: Chart on Kallikrein inhibitor – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Kallikrein inhibitor – Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Kallikrein inhibitor – Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Kallikrein inhibitor – Year-over-year growth 2022-2027 (%)
o 7.6 Others – Market size and forecast 2022-2027
o Exhibit 64: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by Product
o Exhibit 68: Market opportunity by Product ($ million)
o Exhibit 69: Data Table on Market opportunity by Product ($ million)
8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 75: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 79: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 83: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 87: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 91: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 China – Market size and forecast 2022-2027
o Exhibit 95: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 99: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 Canada – Market size and forecast 2022-2027
o Exhibit 103: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.11 India – Market size and forecast 2022-2027
o Exhibit 107: Chart on India – Market size and forecast 2022-2027 ($ million)
o Exhibit 108: Data Table on India – Market size and forecast 2022-2027 ($ million)
o Exhibit 109: Chart on India – Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on India – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ million)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 Adverum Biotechnologies Inc.
o Exhibit 119: Adverum Biotechnologies Inc. – Overview
o Exhibit 120: Adverum Biotechnologies Inc. – Product / Service
o Exhibit 121: Adverum Biotechnologies Inc. – Key offerings
o 12.4 Arrowhead Pharmaceuticals Inc.
o Exhibit 122: Arrowhead Pharmaceuticals Inc. – Overview
o Exhibit 123: Arrowhead Pharmaceuticals Inc. – Business segments
o Exhibit 124: Arrowhead Pharmaceuticals Inc. – Key offerings
o Exhibit 125: Arrowhead Pharmaceuticals Inc. – Segment focus
o 12.5 Attune Pharmaceuticals Inc.
o Exhibit 126: Attune Pharmaceuticals Inc. – Overview
o Exhibit 127: Attune Pharmaceuticals Inc. – Product / Service
o Exhibit 128: Attune Pharmaceuticals Inc. – Key offerings
o 12.6 BioCryst Pharmaceuticals Inc.
o Exhibit 129: BioCryst Pharmaceuticals Inc. – Overview
o Exhibit 130: BioCryst Pharmaceuticals Inc. – Product / Service
o Exhibit 131: BioCryst Pharmaceuticals Inc. – Key offerings
o 12.7 BioMarin Pharmaceutical Inc.
o Exhibit 132: BioMarin Pharmaceutical Inc. – Overview
o Exhibit 133: BioMarin Pharmaceutical Inc. – Product / Service
o Exhibit 134: BioMarin Pharmaceutical Inc. – Key offerings
o 12.8 CENTOGENE NV
o Exhibit 135: CENTOGENE NV – Overview
o Exhibit 136: CENTOGENE NV – Product / Service
o Exhibit 137: CENTOGENE NV – Key offerings
o 12.9 Cipla Ltd.
o Exhibit 138: Cipla Ltd. – Overview
o Exhibit 139: Cipla Ltd. – Business segments
o Exhibit 140: Cipla Ltd. – Key news
o Exhibit 141: Cipla Ltd. – Key offerings
o Exhibit 142: Cipla Ltd. – Segment focus
o 12.10 CSL Ltd.
o Exhibit 143: CSL Ltd. – Overview
o Exhibit 144: CSL Ltd. – Business segments
o Exhibit 145: CSL Ltd. – Key news
o Exhibit 146: CSL Ltd. – Key offerings
o Exhibit 147: CSL Ltd. – Segment focus
o 12.11 Intellia Therapeutics Inc.
o Exhibit 148: Intellia Therapeutics Inc. – Overview
o Exhibit 149: Intellia Therapeutics Inc. – Business segments
o Exhibit 150: Intellia Therapeutics Inc. – Key offerings
o Exhibit 151: Intellia Therapeutics Inc. – Segment focus
o 12.12 Ionis Pharmaceuticals Inc.
o Exhibit 152: Ionis Pharmaceuticals Inc. – Overview
o Exhibit 153: Ionis Pharmaceuticals Inc. – Business segments
o Exhibit 154: Ionis Pharmaceuticals Inc. – Key news
o Exhibit 155: Ionis Pharmaceuticals Inc. – Key offerings
o Exhibit 156: Ionis Pharmaceuticals Inc. – Segment focus
o 12.13 KalVista Pharmaceuticals Inc.
o Exhibit 157: KalVista Pharmaceuticals Inc. – Overview
o Exhibit 158: KalVista Pharmaceuticals Inc. – Product / Service
o Exhibit 159: KalVista Pharmaceuticals Inc. – Key offerings
o 12.14 Pharming Group NV
o Exhibit 160: Pharming Group NV – Overview
o Exhibit 161: Pharming Group NV – Business segments
o Exhibit 162: Pharming Group NV – Key offerings
o Exhibit 163: Pharming Group NV – Segment focus
o 12.15 Pharvaris NV
o Exhibit 164: Pharvaris NV – Overview
o Exhibit 165: Pharvaris NV – Product / Service
o Exhibit 166: Pharvaris NV – Key offerings
o 12.16 Sanofi
o Exhibit 167: Sanofi – Overview
o Exhibit 168: Sanofi – Business segments
o Exhibit 169: Sanofi – Key news
o Exhibit 170: Sanofi – Key offerings
o Exhibit 171: Sanofi – Segment focus
o 12.17 Takeda Pharmaceutical Co. Ltd.
o Exhibit 172: Takeda Pharmaceutical Co. Ltd. – Overview
o Exhibit 173: Takeda Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 174: Takeda Pharmaceutical Co. Ltd. – Key news
o Exhibit 175: Takeda Pharmaceutical Co. Ltd. – Key offerings
13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 176: Inclusions checklist
o Exhibit 177: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 178: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 179: Research methodology
o Exhibit 180: Validation techniques employed for market sizing
o Exhibit 181: Information sources
o 13.5 List of abbreviations
o Exhibit 182: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by End-user
Exhibits6: Executive Summary – Chart on Market Segmentation by Product
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global hereditary angioedema therapeutics market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – End-User Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on End-user – Market share 2022-2027 (%)
Exhibits31: Data Table on End-user – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Hospital pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Hospital pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Retail pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Retail pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Retail pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Retail pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on E-commerce – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on E-commerce – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on E-commerce – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on E-commerce – Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by End-user ($ million)
Exhibits47: Data Table on Market opportunity by End-user ($ million)
Exhibits48: Chart on Product – Market share 2022-2027 (%)
Exhibits49: Data Table on Product – Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Product
Exhibits51: Data Table on Comparison by Product
Exhibits52: Chart on C1-esterase inhibitor – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on C1-esterase inhibitor – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on C1-esterase inhibitor – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on C1-esterase inhibitor – Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Bradykinin B2 receptor antagonist – Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Bradykinin B2 receptor antagonist – Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Bradykinin B2 receptor antagonist – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Bradykinin B2 receptor antagonist – Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Kallikrein inhibitor – Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Kallikrein inhibitor – Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Kallikrein inhibitor – Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Kallikrein inhibitor – Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits65: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits66: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits68: Market opportunity by Product ($ million)
Exhibits69: Data Table on Market opportunity by Product ($ million)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on India – Market size and forecast 2022-2027 ($ million)
Exhibits108: Data Table on India – Market size and forecast 2022-2027 ($ million)
Exhibits109: Chart on India – Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on India – Year-over-year growth 2022-2027 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ million)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits113: Impact of drivers and challenges in 2022 and 2027
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: Adverum Biotechnologies Inc. – Overview
Exhibits120: Adverum Biotechnologies Inc. – Product / Service
Exhibits121: Adverum Biotechnologies Inc. – Key offerings
Exhibits122: Arrowhead Pharmaceuticals Inc. – Overview
Exhibits123: Arrowhead Pharmaceuticals Inc. – Business segments
Exhibits124: Arrowhead Pharmaceuticals Inc. – Key offerings
Exhibits125: Arrowhead Pharmaceuticals Inc. – Segment focus
Exhibits126: Attune Pharmaceuticals Inc. – Overview
Exhibits127: Attune Pharmaceuticals Inc. – Product / Service
Exhibits128: Attune Pharmaceuticals Inc. – Key offerings
Exhibits129: BioCryst Pharmaceuticals Inc. – Overview
Exhibits130: BioCryst Pharmaceuticals Inc. – Product / Service
Exhibits131: BioCryst Pharmaceuticals Inc. – Key offerings
Exhibits132: BioMarin Pharmaceutical Inc. – Overview
Exhibits133: BioMarin Pharmaceutical Inc. – Product / Service
Exhibits134: BioMarin Pharmaceutical Inc. – Key offerings
Exhibits135: CENTOGENE NV – Overview
Exhibits136: CENTOGENE NV – Product / Service
Exhibits137: CENTOGENE NV – Key offerings
Exhibits138: Cipla Ltd. – Overview
Exhibits139: Cipla Ltd. – Business segments
Exhibits140: Cipla Ltd. – Key news
Exhibits141: Cipla Ltd. – Key offerings
Exhibits142: Cipla Ltd. – Segment focus
Exhibits143: CSL Ltd. – Overview
Exhibits144: CSL Ltd. – Business segments
Exhibits145: CSL Ltd. – Key news
Exhibits146: CSL Ltd. – Key offerings
Exhibits147: CSL Ltd. – Segment focus
Exhibits148: Intellia Therapeutics Inc. – Overview
Exhibits149: Intellia Therapeutics Inc. – Business segments
Exhibits150: Intellia Therapeutics Inc. – Key offerings
Exhibits151: Intellia Therapeutics Inc. – Segment focus
Exhibits152: Ionis Pharmaceuticals Inc. – Overview
Exhibits153: Ionis Pharmaceuticals Inc. – Business segments
Exhibits154: Ionis Pharmaceuticals Inc. – Key news
Exhibits155: Ionis Pharmaceuticals Inc. – Key offerings
Exhibits156: Ionis Pharmaceuticals Inc. – Segment focus
Exhibits157: KalVista Pharmaceuticals Inc. – Overview
Exhibits158: KalVista Pharmaceuticals Inc. – Product / Service
Exhibits159: KalVista Pharmaceuticals Inc. – Key offerings
Exhibits160: Pharming Group NV – Overview
Exhibits161: Pharming Group NV – Business segments
Exhibits162: Pharming Group NV – Key offerings
Exhibits163: Pharming Group NV – Segment focus
Exhibits164: Pharvaris NV – Overview
Exhibits165: Pharvaris NV – Product / Service
Exhibits166: Pharvaris NV – Key offerings
Exhibits167: Sanofi – Overview
Exhibits168: Sanofi – Business segments
Exhibits169: Sanofi – Key news
Exhibits170: Sanofi – Key offerings
Exhibits171: Sanofi – Segment focus
Exhibits172: Takeda Pharmaceutical Co. Ltd. – Overview
Exhibits173: Takeda Pharmaceutical Co. Ltd. – Product / Service
Exhibits174: Takeda Pharmaceutical Co. Ltd. – Key news
Exhibits175: Takeda Pharmaceutical Co. Ltd. – Key offerings
Exhibits176: Inclusions checklist
Exhibits177: Exclusions checklist
Exhibits178: Currency conversion rates for US$
Exhibits179: Research methodology
Exhibits180: Validation techniques employed for market sizing
Exhibits181: Information sources
Exhibits182: List of abbreviations

※본 조사보고서 [세계의 유전성 혈관 부종 (HAE) 치료제 시장 2023-2027] (코드 : IRTNTR75935-23) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 유전성 혈관 부종 (HAE) 치료제 시장 2023-2027] 에 대해서 E메일 문의는 여기를 클릭하세요.

*** 아래는 관련 보고서 소개입니다 ***

세계의 뇌 및 조직 산소 측정기 시장 (2023~2027) : 모듈러형, 소지형
IRTNTR41566-23 / Technavio / 2023년 1월 / Technavio사(테크나비오)의 시장 조사 보고서는 세계의 뇌 및 조직 산소 측정기 시장 규모가 2022년부터 2027년 사이에 73.7백만 달러로 성장하며, CAGR은 6.77% 확대될 것으로 전망하고 있습니다. 또한 본 조사 자료는 세계의 뇌...Global Cerebral and Tissue Oximetry Devices Market 2023-2027 Technavio has been monitoring the cerebral and tissue oximetry devices market and is forecast to grow by $73.7 mn during 2022-2027, accelerating at a CAGR of 6.77% during the forecast period. Our report on the cerebral and tissue oximetry devices market provides...

세계의 마취 호흡 회로 시장 (2023~2027) : 병원, 외래 수술 센터, 진료소
IRTNTR74925-23 / Technavio / 2023년 1월 / Technavio사(테크나비오)는 세계의 마취 호흡 회로 시장 규모가 2022년부터 2027년 사이에 416.38백만 달러에 달하며, 예측 기간 동안 연평균 8.22% 성장할 것으로 전망하고 있습니다. 본 조사 보고서는 세계의 마취 호흡 회로 시장에...Global Anesthesia Breathing Circuits Market 2023-2027Technavio has been monitoring the anesthesia breathing circuits market and is forecast to grow by $416.38 mn during 2022-2027, accelerating at a CAGR of 8.22% during the forecast period. Our report on the anesthesia breathing circuits market provides a holistic analysis, market size and forecast,...

세계의 정형 외과 기기 시장 (2023~2027) : 척추, 무릎, 허리, 사지, 기타
IRTNTR43597-23 / Technavio / 2023년 2월 / Technavio사(테크나비오)의 본 조사 보고서는 세계의 정형 외과 기기 시장 규모가 2023년부터 2027년 사이에 121.1억 달러에 달하며, 예측 기간 중 연평균 성장률은 3.85%가 될 것으로 전망하고 있습니다. 본 보고서는 세계의 정형...Global Orthopedic Device Market 2023-2027Technavio has been monitoring the orthopedic device market and is forecast to grow by $12.11 bn during 2022-2027, accelerating at a CAGR of 3.85% during the forecast period. Our report on the orthopedic device market provides a holistic analysis, market size and forecast, trends, growth drivers,...

세계의 의약품 제조 장비 시장 2023-2027
IRTNTR76013-23 / Technavio / 2023년 7월 / 글로벌 의약품 제조 장비 시장 2023-2027 의약품 제조 장비 시장은 2022년부터 2027년까지 5억 4,544만 달러 규모로 성장할 것으로 예상되며, 예측 기간 동안 6.67%의 CAGR을 기록할 것으로 예상됩니다. 이 보고서는 의약품...1. 개요 2. 세계의 의약품 제조 장비 시장 현황 3. 세계의 의약품 제조 장비 시장 규모 4. 과거 시장 규모 5. 파이브 포스 분석 6. 제품 유형별 시장 분석 7. 유형별 시장 분석 8. 고객 현황 9. 지역별 분석 10. 추진 요인/과제/동향 11. 기업 현황 12. 기업 분석 13. 부록...

세계의 기록용 차트 용지 시장 (2024-2028)
IRTNTR77688-24 / Technavio / 2024년 3월 / 세계의 기록용 차트 용지 시장 2024-2028기록용 차트 용지 시장은 2023년부터 2028년까지 7억 5,371만 달러로 성장할 것으로 예상되며, 예측 기간 동안 6.01%의 CAGR로 성장할 것으로 전망됩니다. 이 보고서는 기록용 차트 용지...1. 개요 2. 시장 현황 3. 시장 규모 4. 과거 시장 규모 5. 파이브 포스 분석 6. 세계의 기록용 차트 용지 시장 규모 : 용도별 7. 세계의 기록용 차트 용지 시장 규모 : 유형별 8. 고객 현황 9. 지리적 현황 10. 추진 요인, 과제, 동향 11. 기업 현황 12. 기업...

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!